The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
August 27th 2025
The FDA's approvals follows new COVID-19 guidance announced by the commissioner of the agency in May 2025, focusing future approvals on older adults.
Pediatric Indication for Teflaro Pending FDA Review
February 16th 2016The FDA is reviewing Allergan's supplemental new drug application for ceftaroline fosamil to treat children aged 2 months and older with acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia.
Read More